SCHEMBL3675252

SCHEMBL3675252

CC(=O)Nc1cccc(-c2ccc(OCc3ccccc3)cc2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.65
NPC1 O15118 2/20 0.65
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
MGLL Q99685 2/20 0.60
NR1H4 Q96RI1 3/20 0.60
LMNA P02545 1/20 0.60
TNF P01375 1/20 0.55
NOD2 Q9HC29 1/20 0.55
NOD1 Q9Y239 1/20 0.55
CYP17A1 P05093 1/20 0.55
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
ENPP2 Q13822 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
F10 P00742 1/20 0.55
MCL1 Q07820 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450492 0.89 ENPP2 (0.56) RAB9ANPC1MEN1KMT2AMGLL
SCHEMBL4444734 0.89 NR1H4 (0.69) RAB9ANPC1MEN1KMT2ANR1H4
SCHEMBL5263392 0.86 NPC1 (0.49) RAB9ANPC1MEN1KMT2AMGLL
SCHEMBL10599853 0.85 MEN1 (0.79) RAB9ANPC1MEN1KMT2ANR1H4
SCHEMBL3294745 0.85 NPC1 (0.54) RAB9ANPC1MEN1KMT2ANR1H4
SCHEMBL2750411 0.83 SMN1; SMN2 (0.75) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL3786463 0.82 NQO2 (0.73) RAB9ANPC1MEN1KMT2AMGLL
SCHEMBL13298071 0.81 MAOB (0.54) MEN1KMT2ANR1H4LMNA
SCHEMBL6204492 0.80 NQO2 (0.55) RAB9ANPC1MEN1KMT2AMGLL
SCHEMBL5906609 0.79 PPARG (0.65) NR1H4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170072-A1 FARNESOID X RECEPTOR AGONISTS GlaxoSmithKline LLC (US) 2010-04-07 EP disclosed
WO-2008157270-A1 FARNESOID X RECEPTOR AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-24 WO disclosed